Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
2076
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.39M | ﹤0.01% |
130,808
+114,447
| +700% | +$1.93M |
|
2077
Titan Machinery
TITN
$429M
| $2.38M | ﹤0.01% |
181,343
+37,691
| +26% | +$561K |
|
2078
Mettler-Toledo International
MTD
$28.2B
| $2.38M | ﹤0.01% |
4,212
+2,052
| +95% | +$1.19M |
|
2079
Freshpet
FRPT
$3.5B
| $2.38M | ﹤0.01% |
+73,959
| New | +$2.57M |
|
2080
Pembina Pipeline
PBA
$28.1B
| $2.37M | ﹤0.01% |
79,901
-299,185
| -79% | -$9.92M |
|
2081
Sunstone Hotel Investors
SHO
$2.08B
| $2.37M | ﹤0.01% |
182,056
+119,996
| +193% | +$1.77M |
|
2082
Donaldson
DCI
$10.7B
| $2.37M | ﹤0.01% |
54,545
-225,299
| -81% | -$11.6M |
|
2083
CALL
Henry Schein
HSIC
$10.1B
| $2.36M | ﹤0.01% |
38,250
+25,500
| +200% | +$1.68M |
|
|
VBTX
2084
DELISTED
Veritex Holdings
VBTX
| $2.35M | ﹤0.01% |
110,005
-302,407
| -73% | -$7.39M |
|
|
FPF
2085
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
| $2.34M | ﹤0.01% |
118,301
+94,401
| +395% | +$1.89M |
|
2086
Main Street Capital
MAIN
$5.48B
| $2.34M | ﹤0.01% |
69,260
+5,186
| +8% | +$193K |
|
2087
IQVIA
IQV
$43.2B
| $2.34M | ﹤0.01% |
20,129
-44,903
| -69% | -$5.44M |
|
2088
CALL
Universal Health Services
UHS
$10.2B
| $2.33M | ﹤0.01% |
+20,000
| New | +$2.51M |
|
|
WFT
2089
DELISTED
Weatherford International plc
WFT
| $2.33M | ﹤0.01% |
4,167,085
-17,307,562
| -81% | -$22.6M |
|
|
MRSH
2090
Marsh
MRSH
$90.7B
| $2.33M | ﹤0.01% |
29,163
+22,677
| +350% | +$1.89M |
|
2091
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $2.32M | ﹤0.01% |
60,962
+32,278
| +113% | +$1.25M |
|
2092
Gyre Therapeutics
GYRE
$708M
| $2.31M | ﹤0.01% |
39,045
-7,333
| -16% | -$541K |
|
2093
iShares 7-10 Year Treasury Bond ETF
IEF
$43B
| $2.31M | ﹤0.01% |
+22,178
| New | +$2.25M |
|
|
PGNX
2094
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.31M | ﹤0.01% |
+548,953
| New | +$2.8M |
|
2095
Dine Brands
DIN
$422M
| $2.31M | ﹤0.01% |
34,222
-101,422
| -75% | -$8.39M |
|
2096
Mercury Systems
MRCY
$5.44B
| $2.3M | ﹤0.01% |
48,681
+43,711
| +879% | +$2.13M |
|
2097
PUT
Edwards Lifesciences
EW
$51.8B
| $2.3M | ﹤0.01% |
45,000
-540,000
| -92% | -$27.3M |
|
2098
PUT
ICU Medical
ICUI
$4.38B
| $2.3M | ﹤0.01% |
10,000
-5,000
| -33% | -$1.23M |
|
2099
iShares MBS ETF
MBB
$39.2B
| $2.3M | ﹤0.01% |
+21,939
| New | +$2.26M |
|
|
VIOT
2100
Viomi Technology
VIOT
$55.2M
| $2.29M | ﹤0.01% |
294,166
-143,453
| -33% | -$1.22M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.